Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Treatment of patients classified by histologic grade, rCBV, and ADC values
Histologic Grade No Adjuvant Therapy Radiotherapy Chemotherapy (TMZ) Chemoradiotherapy Total
Grade II 7 (5.6%) 2 (1.6%) 14 (11.2%) 7 (5.6%) 24%
Grade III 1 (0.8%) 0 (0%) 6 (4.8%) 11 (8.8%) 14.4%
Grade IV 13 (10.4%) 0 (0%) 2 (1.6%) 63 (49.6%) 61.6%
Total 16.8% 1.6% 17.6% 64% 100%
rCBV values 
    rCBV ≥ 5.195 11 (8.7%) 0 (0.0%) 4 (3.2%) 48 (38.1%) 50%
    rCBV < 5.195 11 (8.7%) 2 (1.6%) 18 (14.3%) 32 (25.4%) 50%
Total 17.5% 1.6% 17.5% 63.5% 100%
ADC values 
    ADC < 0.799 × 10⁻³ mm²/s 13 (10.3%) 0 (0.0%) 3 (2.3%) 47 (37.4%) 50%
    ADC ≥ 0.799 × 10⁻³ mm²/s 8 (6.4%) 2 (1.6%) 19 (15%) 34 (27%) 50%
Total 16.7% 1.6% 17.3% 64.4% 100%
Note:—TMZ indicates temozolomide.

Histologic Grade	No Adjuvant Therapy	Radiotherapy	Chemotherapy (TMZ)	Chemoradiotherapy	Total
Grade II	7 (5.6%)	2 (1.6%)	14 (11.2%)	7 (5.6%)	24%
Grade III	1 (0.8%)	0 (0%)	6 (4.8%)	11 (8.8%)	14.4%
Grade IV	13 (10.4%)	0 (0%)	2 (1.6%)	63 (49.6%)	61.6%
Total	16.8%	1.6%	17.6%	64%	100%
rCBV values
rCBV ≥ 5.195	11 (8.7%)	0 (0.0%)	4 (3.2%)	48 (38.1%)	50%
rCBV < 5.195	11 (8.7%)	2 (1.6%)	18 (14.3%)	32 (25.4%)	50%
Total	17.5%	1.6%	17.5%	63.5%	100%
ADC values
ADC < 0.799 × 10⁻³ mm²/s	13 (10.3%)	0 (0.0%)	3 (2.3%)	47 (37.4%)	50%
ADC ≥ 0.799 × 10⁻³ mm²/s	8 (6.4%)	2 (1.6%)	19 (15%)	34 (27%)	50%
Total	16.7%	1.6%	17.3%	64.4%	100%